New excipients on show at CPhl Worldwide in Madrid
New excipients will be on show at a pharmaceuticals event in Madrid later this month.
The CPhl Worldwide event is one of the most important events in the calendar for pharma manufacturers, buyers and service suppliers and is expected to attract nearly 30,000 attendees from 133 countries when it takes place.
One exhibitor that will be showing its products from now until October 11th is Evonik Industries AG, which is involved in the creation of pharmaceutical ingredients such as excipients.
The company's inorganic materials business unit will provide a lecture on its Aeroperl 300 Pharma excipient, which Evonik claims offers "versatile advantages for an efficient pharmaceutical production", with the talk set to take place at 13.00 on October 10th at the Speaker's Corner.
As well as excipients and formulations, the event will bring together industry representatives from areas including biopharma, fine chemicals, custom manufacturing, APIs and finished dosage.
Visitors to the event will have opportunity to meet some 2,200 exhibitors face to face, as well as staying informed about the latest industry trends.
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...